Monday’s session was the kind of day that reminds you markets are not a calm calculator — they’re a live nervous system.
U.S. stocks opened the week in near-panic mode after an overnight oil surge tied to the escalating Iran conflict, only to stage a dramatic late-day reversal after President Donald Trump suggested the war was essentially “very complete.” The result: a full “fear-to-relief” round trip, with tech leading the rebound and travel names getting crushed by fuel-price anxiety.
A brutal open… then a full reversal into the close
The day began with the market fixated on one thing: energy shock.
Oil had surged overnight — with U.S. crude and Brent briefly flirting with $111–$120 levels in futures trading — and equities opened in the red:
- Russell 2000 down the most early (small caps hate inflation spikes)
- Dow, S&P 500, Nasdaq also lower at the open
- Volatility jumped, with the VIX around 31
But by the final hour, the tone shifted. The Nasdaq clawed back to flat, then pushed into a sharp rally, and stocks closed at their highs of the day:
- Nasdaq: +1.38% (22,695.95)
- S&P 500: +0.83% (6,795.99)
- Dow: +0.50% (47,740.80)
- Russell 2000: +1.12% (2,553.67)
The catalyst was Trump’s “conflict is basically over” framing — enough to spark a relief rally even as the broader situation remained unstable.
Oil whiplash is running the entire show
This session was ultimately an oil story disguised as a stock story.
- Overnight: crude exploded higher on fear that the Strait of Hormuz disruption could spiral.
- Morning: oil cooled to around the $100 zone, calming the “inflation shock” narrative.
- Afternoon: after Trump’s comments, oil slid below $90 at one point, taking pressure off rate expectations and allowing stocks to breathe.
The market’s takeaway was simple: if oil stays elevated, rate cuts get harder; if oil falls, the Fed story softens and risk assets can bounce.
The winners: biotech rockets and “risk-on” snaps back
Even in a geopolitical tape, stock pickers had plenty to chew on.
Top upside movers
- Xenon Pharmaceuticals (+48.8%): surged after strong trial results for a daily seizure pill, with data described as stronger than expected.
- Hims & Hers (+39.9%): rebounded sharply after announcing a partnership with Novo Nordisk tied to weight-loss drugs, alongside news it would drop a patent dispute. (Still deeply down year-to-date despite the bounce.)
- Dianthus Therapeutics (+25.4%): climbed on upgrades after interim trial results for a rare autoimmune-disease drug, with analysts pointing to a big potential market.
Early S&P 500 bright spots
Even when the index was mostly red, a few names stood out:
- Live Nation popped after settling a Justice Department lawsuit.
- Moderna jumped as traders reacted to headlines around the FDA’s vaccine leadership shakeup.
- Dow Inc. rose on an analyst upgrade focused on margin opportunities amid global disruptions.
The losers: travel gets smashed, and a rare-earth darling deflates
Higher oil prices act like an immediate tax on anything that moves people long distances.
Travel and leisure pain
Cruise lines and airlines were among the worst performers early and stayed under pressure:
- Carnival, Royal Caribbean, Norwegian were hit hard
- United, Delta, Southwest also slid as jet fuel risk rose
Other notable laggards
- Evolution Metals & Technologies (-11.4%): dropped as traders rotated out of the once-hot rare earth metals trade, extending a steep decline since its Nasdaq uplisting.
- e.l.f. Beauty (-7.9%): fell after prior momentum cooled.
- Grupo Aeromexico (-7.7%): slid amid broader airline weakness and recent operational disruptions.
The tension under the rally: “conflict over” headlines vs. reality on the ground
The late surge was powerful, but the day didn’t end with clarity — it ended with contradiction.
Even as Trump suggested the conflict was largely finished, reports pointed to continued missile activity and rising questions about what “complete” actually means in practice — especially with the Strait of Hormuz still effectively choked by risk, insurance, and tanker hesitation.
Adding to the uncertainty, fresh reports described strikes on critical regional energy infrastructure — including renewed attacks on Bahrain’s Bapco refinery and force majeure declarations — underlining how quickly “energy crisis” can return to the driver’s seat.
What Monday actually told us
This wasn’t a calm “buy-the-dip” session. It was a lesson in the new market reality:
- Oil is the master switch.
Every asset class is still downstream of crude when Middle East shipping is in question. - Tech remains the default refuge when fear fades.
When panic eases, money snaps back to large-cap tech fast. - Travel is the instant casualty of energy shock.
Airlines and cruise lines are the first to get repriced. - Headlines are moving markets more than fundamentals.
A single comment flipped the entire session — that’s the environment we’re in.
What to watch next
If you’re tracking the next move, it’s basically three things:
- Oil direction: Does crude re-accelerate, or keep cooling?
- Hormuz traffic and security: Any tangible change here will reset prices fast.
- Policy response: G7 coordination, shipping escorts, strategic reserve talk — anything credible can calm or inflame the trade.
